NASDAQ:CRON Cronos Group (CRON) Stock Forecast, Price & News $1.75 +0.05 (+2.94%) (As of 06/6/2023 ET) Add Compare Share Share Today's Range$1.66▼$1.7550-Day Range$1.70▼$2.0452-Week Range$1.66▼$3.62Volume854,245 shsAverage Volume1.47 million shsMarket Capitalization$666.44 millionP/E RatioN/ADividend YieldN/APrice Target$3.44 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media Cronos Group MarketRank™ ForecastAnalyst RatingModerate Buy2.67 Rating ScoreUpside/Downside96.4% Upside$3.44 Price TargetShort InterestHealthy4.14% of Float Sold ShortDividend StrengthN/ASustainabilityN/ANews Sentiment0.62Based on 5 Articles This WeekInsider TradingAcquiring Shares$434,250 Bought Last QuarterProj. Earnings GrowthGrowingFrom ($0.13) to ($0.09) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.2.30 out of 5 starsMedical Sector237th out of 981 stocksMedicinals & Botanicals Industry1st out of 9 stocks 3.3 Analyst's Opinion Consensus RatingCronos Group has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 4 buy ratings, 2 hold ratings, and no sell ratings.Price Target Upside/DownsideAccording to analysts' consensus price target of $3.44, Cronos Group has a forecasted upside of 96.4% from its current price of $1.75.Amount of Analyst CoverageCronos Group has only been the subject of 1 research reports in the past 90 days. Previous Next 4.0 Short Interest Percentage of Shares Shorted4.14% of the float of Cronos Group has been sold short.Short Interest Ratio / Days to CoverCronos Group has a short interest ratio ("days to cover") of 5.5.Change versus previous monthShort interest in Cronos Group has recently decreased by 12.63%, indicating that investor sentiment is improving significantly. Previous Next 0.0 Dividend Strength Dividend YieldCronos Group does not currently pay a dividend.Dividend GrowthCronos Group does not have a long track record of dividend growth. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for CRON. Previous Next 2.6 News and Social Media Coverage News SentimentCronos Group has a news sentiment score of 0.62. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.News Coverage This WeekMarketBeat has tracked 5 news articles for Cronos Group this week, compared to 3 articles on an average week.Search Interest6 people have searched for CRON on MarketBeat in the last 30 days. This is an increase of 50% compared to the previous 30 days.MarketBeat FollowsOnly 2 people have added Cronos Group to their MarketBeat watchlist in the last 30 days. This is a decrease of -71% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Cronos Group insiders have bought more of their company's stock than they have sold. Specifically, they have bought $434,250.00 in company stock and sold $0.00 in company stock.Percentage Held by InsidersOnly 1.96% of the stock of Cronos Group is held by insiders.Percentage Held by InstitutionsOnly 11.94% of the stock of Cronos Group is held by institutions. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for Cronos Group are expected to grow in the coming year, from ($0.13) to ($0.09) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Cronos Group is -4.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Cronos Group is -4.27, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioCronos Group has a P/B Ratio of 0.58. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About Cronos Group (NASDAQ:CRON) StockCronos Group, Inc. engages in the production and distribution of cannabis. I It operates through the United States and Rest of World segments. The company was founded on August 21, 2012 and is headquartered in Toronto, Canada.Read More Receive CRON Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cronos Group and its competitors with MarketBeat's FREE daily newsletter. Email Address CRON Stock News HeadlinesJune 4, 2023 | americanbankingnews.comJason Marc Adler Buys 37,500 Shares of Cronos Group Inc. (NASDAQ:CRON) StockJune 2, 2023 | americanbankingnews.comCronos Group Inc. (NASDAQ:CRON) Director Jason Marc Adler Purchases 100,000 SharesJune 7, 2023 | Behind the Markets (Ad)BREAKING: The truth about war with ChinaForeign Affairs reports, "China is Now in a Prewar Tempo of Political and Military Preparations." China has one goal: take control of Taiwan, and an invasion could happen any day. I've identified 5 investments I believe are in immediate danger. But you can get out of them now - before it's too late.June 1, 2023 | msn.comCronos Group (TSE:CRON) Price Target Decreased by 8.81% to 3.48June 1, 2023 | finance.yahoo.com3 Awful Stock Returns That Highlight the Cannabis Industry's Struggles Since 2018May 26, 2023 | finance.yahoo.comUpdate on Altria’s Pending Acquisition of NJOY Holdings, Inc.May 25, 2023 | americanbankingnews.comJason Marc Adler Purchases 100,000 Shares of Cronos Group Inc. (NASDAQ:CRON) StockMay 20, 2023 | americanbankingnews.comCronos Group Inc. (NASDAQ:CRON) Receives Consensus Rating of "Moderate Buy" from AnalystsJune 7, 2023 | Behind the Markets (Ad)"Unknown laser company making HUGE profit from Russia-Ukraine War"On February 24th, Russia invaded Ukraine. This caused major stock losses and soaring gas prices. But it also created a HUGE opportunity for savvy investors. There's an unknown laser company that's been profiting greatly from this war... ...and from another major conflict happening 3,000 miles away. Learn more here >>>May 20, 2023 | americanbankingnews.comCronos Group (NASDAQ:CRON) Shares Up 4%May 20, 2023 | americanbankingnews.comCronos Group (NASDAQ:CRON) Rating Reiterated by Roth CapitalMay 15, 2023 | americanbankingnews.comCronos Group (NASDAQ:CRON) Given New $3.00 Price Target at BarclaysMay 9, 2023 | seekingalpha.comCronos Group, Inc. (CRON) Q1 2023 Earnings Call TranscriptMay 9, 2023 | finanznachrichten.deCronos Group Inc.: Cronos Group Reports 2023 First Quarter ResultsMay 9, 2023 | finance.yahoo.comMorning News Call - Canada, May 9May 9, 2023 | markets.businessinsider.comCronos Q1 2023 Revenue Declines 19.5% YoY, Provides OutlookMay 9, 2023 | msn.comCronos Group reports misses Q1 top and bottom consensus; updates FY23 outlookMay 8, 2023 | msn.comEarnings Outlook For Cronos GroupMay 8, 2023 | msn.comCronos Group Q1 2023 Earnings PreviewMay 8, 2023 | americanbankingnews.comCronos Group (CRON) to Release Quarterly Earnings on TuesdayApril 29, 2023 | theglobeandmail.comCronos Group: Top 10 Undervalued Small Cap Stocks on TSX (CRON)April 29, 2023 | theglobeandmail.comClosing Bell: Cronos Group Inc up on Friday (CRON)April 29, 2023 | americanbankingnews.comCronos Group (NASDAQ:CRON) Shares Gap Up to $1.73April 28, 2023 | marketwatch.comCronos Group Inc. stock rises Friday, outperforms marketApril 28, 2023 | finance.yahoo.comCronos Group Inc. to Hold Virtual 2023 Annual Meeting of ShareholdersApril 25, 2023 | finance.yahoo.comCronos Group Inc. to Hold 2023 First Quarter Earnings Conference Call on May 9, 2023April 25, 2023 | americanbankingnews.comAnalysts Set Cronos Group Inc. (NASDAQ:CRON) Price Target at $3.56See More Headlines CRON Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart CRON Company Calendar Last Earnings8/05/2021Today6/06/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Medicinals & botanicals Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:CRON CUSIPN/A CIK1656472 Webwww.thecronosgroup.com Phone(416) 504-0004FaxN/AEmployees626Year FoundedN/APrice Target and Rating Average Stock Price Forecast$3.44 High Stock Price Forecast$4.75 Low Stock Price Forecast$3.00 Forecasted Upside/Downside+96.4%Consensus RatingModerate Buy Rating Score (0-4)2.67 Research Coverage6 Analysts Profitability EPS (Most Recent Fiscal Year)($0.41) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-168,730,000.00 Net Margins-178.43% Pretax Margin-141.31% Return on Equity-9.65% Return on Assets-9.26% Debt Debt-to-Equity RatioN/A Current Ratio31.45 Quick Ratio29.93 Sales & Book Value Annual Sales$91.90 million Price / Sales7.25 Cash FlowN/A Price / Cash FlowN/A Book Value$3.00 per share Price / Book0.58Miscellaneous Outstanding Shares380,820,000Free Float373,352,000Market Cap$666.44 million OptionableOptionable Beta1.48 Key ExecutivesMichael Ryan GorensteinChairman, President & Chief Executive OfficerJames HolmChief Financial OfficerArye WeigensbergHead-Research & TechnologyJeffrey JacobsonChief Growth OfficerRan GorelikGeneral Manager-IsraelKey CompetitorsCanopy GrowthNASDAQ:CGCbioteNASDAQ:BTMDAurora CannabisNYSE:ACBUSANA Health SciencesNYSE:USNAMiMedx GroupNASDAQ:MDXGView All CompetitorsInsiders & InstitutionsJason Marc AdlerBought 37,500 shares on 5/30/2023Total: $65,250.00 ($1.74/share)Jason Marc AdlerBought 100,000 shares on 5/25/2023Total: $180,000.00 ($1.80/share)Toroso Investments LLCBought 33,335 shares on 5/23/2023Ownership: 0.030%Jason Marc AdlerBought 100,000 shares on 5/19/2023Total: $189,000.00 ($1.89/share)Susquehanna International Group LLPSold 1,133,600 shares on 5/16/2023Ownership: 0.000%View All Insider TransactionsView All Institutional Transactions CRON Stock - Frequently Asked Questions Should I buy or sell Cronos Group stock right now? 6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Cronos Group in the last twelve months. There are currently 2 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" CRON shares. View CRON analyst ratings or view top-rated stocks. What is Cronos Group's stock price forecast for 2023? 6 Wall Street research analysts have issued 12 month price targets for Cronos Group's stock. Their CRON share price forecasts range from $3.00 to $4.75. On average, they expect the company's stock price to reach $3.44 in the next twelve months. This suggests a possible upside of 96.4% from the stock's current price. View analysts price targets for CRON or view top-rated stocks among Wall Street analysts. How have CRON shares performed in 2023? Cronos Group's stock was trading at $2.54 at the beginning of the year. Since then, CRON shares have decreased by 31.1% and is now trading at $1.75. View the best growth stocks for 2023 here. Are investors shorting Cronos Group? Cronos Group saw a decrease in short interest during the month of May. As of May 15th, there was short interest totaling 8,230,000 shares, a decrease of 12.6% from the April 30th total of 9,420,000 shares. Based on an average daily volume of 1,490,000 shares, the short-interest ratio is currently 5.5 days. Currently, 4.1% of the company's stock are sold short. View Cronos Group's Short Interest. When is Cronos Group's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our CRON earnings forecast. How were Cronos Group's earnings last quarter? Cronos Group Inc. (NASDAQ:CRON) announced its quarterly earnings data on Thursday, August, 5th. The company reported $0.15 earnings per share for the quarter, beating analysts' consensus estimates of ($0.07) by $0.22. The company had revenue of $15.60 million for the quarter, compared to the consensus estimate of $18.48 million. Cronos Group had a negative trailing twelve-month return on equity of 9.65% and a negative net margin of 178.43%. The business's revenue for the quarter was up 57.6% on a year-over-year basis. During the same quarter last year, the company posted ($0.31) earnings per share. What guidance has Cronos Group issued on next quarter's earnings? Cronos Group updated its FY 2023 earnings guidance on Tuesday, May, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $100.00 million-$110.00 million, compared to the consensus revenue estimate of $102.93 million. What other stocks do shareholders of Cronos Group own? Based on aggregate information from My MarketBeat watchlists, some companies that other Cronos Group investors own include Aurora Cannabis (ACB), Tilray (TLRY), NVIDIA (NVDA), Advanced Micro Devices (AMD), Dollar Tree (DLTR), Micron Technology (MU), Alibaba Group (BABA) and Organigram (OGI). What is Cronos Group's stock symbol? Cronos Group trades on the NASDAQ under the ticker symbol "CRON." Who are Cronos Group's major shareholders? Cronos Group's stock is owned by a number of retail and institutional investors. Top institutional investors include ETF Managers Group LLC (1.45%), Dimensional Fund Advisors LP (0.39%), Intact Investment Management Inc. (0.30%), Mirae Asset Global Investments Co. Ltd. (0.26%), Penserra Capital Management LLC (0.14%) and Swiss National Bank (0.12%). Insiders that own company stock include Jason Marc Adler, Michael Ryan Gorenstein and Todd Kevin Abraham. View institutional ownership trends. How do I buy shares of Cronos Group? Shares of CRON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is Cronos Group's stock price today? One share of CRON stock can currently be purchased for approximately $1.75. How much money does Cronos Group make? Cronos Group (NASDAQ:CRON) has a market capitalization of $666.44 million and generates $91.90 million in revenue each year. The company earns $-168,730,000.00 in net income (profit) each year or ($0.41) on an earnings per share basis. How many employees does Cronos Group have? The company employs 626 workers across the globe. How can I contact Cronos Group? Cronos Group's mailing address is 111 PETER STREET SUITE 300, TORONTO A6, M5V 2G9. The official website for the company is www.thecronosgroup.com. The company can be reached via phone at (416) 504-0004. This page (NASDAQ:CRON) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cronos Group Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.